314 related articles for article (PubMed ID: 24631042)
1. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
Zhang L; Li P; Xing CY; Zhao JY; He YN; Wang JQ; Wu XF; Liu ZS; Zhang AP; Lin HL; Ding XQ; Yin AP; Yuan FH; Fu P; Hao L; Miao LN; Xie RJ; Wang R; Zhou CH; Guan GJ; Hu Z; Lin S; Chang M; Zhang M; He LQ; Mei CL; Wang L; Chen X
Am J Kidney Dis; 2014 Jul; 64(1):57-65. PubMed ID: 24631042
[TBL] [Abstract][Full Text] [Related]
2. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
Li P; Chen YZ; Lin HL; Ni ZH; Zhan YL; Wang R; Yang HT; Fang JA; Wang NS; Li WG; Sun XF; Chen XM
Trials; 2017 Apr; 18(1):170. PubMed ID: 28395659
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
Chen Y; Deng Y; Ni Z; Chen N; Chen X; Shi W; Zhan Y; Yuan F; Deng W; Zhong Y
Am J Kidney Dis; 2013 Dec; 62(6):1068-76. PubMed ID: 23810688
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial.
Kou J; Wu J; Yang HT; He YN; Fang JA; Deng YY; Xie YS; Nie LF; Lin HL; Cai GY; Chen XM
Trials; 2014 Dec; 15():479. PubMed ID: 25480673
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic kidney disease using a traditional Chinese medicine, Flos Abelmoschus manihot (Linnaeus) Medicus (Malvaceae).
Chen Y; Cai G; Sun X; Chen X
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):145-8. PubMed ID: 26667396
[TBL] [Abstract][Full Text] [Related]
6. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial.
Wang YJ; He LQ; Sun W; Lu Y; Wang XQ; Zhang PQ; Wei LB; Cao SL; Yang NZ; Ma HZ; Gao J; Li P; Tao XJ; Yuan FH; Li J; Yao C; Liu X
J Ethnopharmacol; 2012 Feb; 139(3):757-64. PubMed ID: 22178174
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Abelmoschus manihot for IgA nephropathy: A multicenter randomized clinical trial.
Li P; Lin H; Ni Z; Zhan Y; He Y; Yang H; Fang J; Wang N; Li W; Cai G; Chen Y; Zhang P; Wang X; Chen Q; Li Z; Sun X; Chen X
Phytomedicine; 2020 May; 76():153231. PubMed ID: 32535481
[TBL] [Abstract][Full Text] [Related]
8. [Syndrome differentiation-based treatment with traditional Chinese medicine for proteinuria in patients with chronic kidney disease: a randomized multicenter trial].
Wang D; Wu T; Xie T; Peng W; Wang Y; Yuan M; Mi X; Bi Y; He L
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):502-6. PubMed ID: 23644107
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial.
Wu J; Duan SW; Yang HT; Deng YY; Li W; He YN; Ni ZH; Zhan YL; Lin S; Guo ZY; Zhu J; Fang JA; Liu XS; Wang LH; Wang R; Wang NS; Cheng XH; He LQ; Luo P; Sun SR; Sun JF; Yin AP; Jiang GR; Chen HY; Liu WH; Lin HL; Liang M; Ma L; Chen M; Song LQ; Chen J; Zhu Q; Xing CY; Li Y; Gao JN; Li RS; Li Y; Zhang H; Lu Y; Zhou QL; Fu JZ; He Q; Cai GY; Chen XM
J Integr Med; 2021 Mar; 19(2):111-119. PubMed ID: 33589406
[TBL] [Abstract][Full Text] [Related]
10. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases.
Li N; Tang H; Wu L; Ge H; Wang Y; Yu H; Zhang X; Ma J; Gu HF
Phytother Res; 2021 Jan; 35(1):198-206. PubMed ID: 32716080
[TBL] [Abstract][Full Text] [Related]
11. Glomerular disease. Antiproteinuric efficacy of A. manihot superior to losartan.
Carney EF
Nat Rev Nephrol; 2014 Jun; 10(6):300. PubMed ID: 24709846
[No Abstract] [Full Text] [Related]
12. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms and effects of Abelmoschus manihot preparations in treating chronic kidney disease].
Chen P; Wan Y; Wang C; Zhao Q; Wei Q; Tu Y; Yin X
Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2252-6. PubMed ID: 23189729
[TBL] [Abstract][Full Text] [Related]
14. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, ameliorates adriamycin-induced renal inflammation and glomerular injury via inhibiting p38MAPK signaling pathway activity in rats.
Tu Y; Sun W; Wan YG; Che XY; Pu HP; Yin XJ; Chen HL; Meng XJ; Huang YR; Shi XM
J Ethnopharmacol; 2013 May; 147(2):311-20. PubMed ID: 23518420
[TBL] [Abstract][Full Text] [Related]
15. [Multi-center randomized control study on the effects of syndrome differentiated traditional Chinese medicine therapy on CKD 1-2 with chronic nephritis proteinuria].
Wu F; Zhang PQ; Wang XQ; Nie LF; Fu XJ; Peng W; Wang Y; Li J; Bi YP; Mi XH; Ding XQ; He LQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 46(1):145-8. PubMed ID: 25807814
[TBL] [Abstract][Full Text] [Related]
16. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
17. [Efficiency of benazepril combined with wind dispelling and dampness removing chinese herbs on stage 3 chronic kidney disease with wind-dampness syndrome: a prospective study].
Fang YQ; Lu Y; Wang YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Mar; 32(3):311-6. PubMed ID: 22686073
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study.
Zheng Y; Cai GY; He LQ; Lin HL; Cheng XH; Wang NS; Jian GH; Liu XS; Liu YN; Ni ZH; Fang JA; Ding HL; Guo W; He YN; Wang LH; Wang YP; Yang HT; Ye ZM; Yu RH; Zhao LJ; Zhou WH; Li WG; Mao HJ; Zhan YL; Hu Z; Yao C; Wei RB; Chen XM
Chin Med J (Engl); 2017 Oct; 130(20):2402-2409. PubMed ID: 29052559
[TBL] [Abstract][Full Text] [Related]
19. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
Gan J; Wu Y; Gong X; Ma Y; Yu S; Gao J
Trials; 2019 Aug; 20(1):481. PubMed ID: 31391092
[TBL] [Abstract][Full Text] [Related]
20. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
